| Current Price | $9.14 | Mkt Cap | $4.0B |
|---|---|---|---|
| Open | $9.21 | P/E Ratio | 0.00 |
| Prev. Close | $9.14 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $8.87 - $9.64 | Volume | 13,135 |
| 52-Wk Range | $7.01 - $18.16 | Avg. Daily Vol. | 3,255,684 |
23andMe, Inc., headquartered in Sunnyvale, CA, is a leading consumer genetics and research company. Founded in 2006, 23andMe's mission is to help people access, understand, and benefit from the human genome. 23andMe has pioneered direct access to genetic information as the only company with multiple Food and Drug Administration authorizations for genetic health risk reports. 23andMe has created the world's largest crowdsourced platform for genetic research, with 80% of its customers electing to participate.
| Current Price | $9.14 | Mkt Cap | $4.0B |
|---|---|---|---|
| Open | $9.21 | P/E Ratio | 0.00 |
| Prev. Close | $9.14 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $8.87 - $9.64 | Volume | 13,135 |
| 52-Wk Range | $7.01 - $18.16 | Avg. Daily Vol. | 3,255,684 |
The best Bull and Bear pitches based on recency and number of recommendations.
Almost doubled after buying on-line health service, Lemonaid. A friend of mine used their platform and was extremely impressed with both their ancestral lineage DNA detection and also their very detailed genetic health analysis. Lets see where this… More
There are no pitches that meet the Top Bear criteria. Explain
If this upsets you, start recommending pitches below!
Read the most recent pitches from players about ME.
Recs
RNInvestor
(< 20)
Submitted: 11/16/2021 7:29:03 AM :
Start Price:
$10.84
NASDAQ:ME Score:
-13.90
The pivot into the utilization of genetic data to create novel therapeutics is promising. In addition to the consumer business that is already in place drug approvals could significantly drive up revenue for very little cost to the company.
Recs
NHWeston102
(76.61)
Submitted: 11/6/2021 3:21:45 PM :
Start Price:
$13.33
NASDAQ:ME Score:
-29.15
Almost doubled after buying on-line health service, Lemonaid. A friend of mine used their platform and was extremely impressed with both their ancestral lineage DNA detection and also their very detailed genetic health analysis. Lets see where this goes.
Recs
KPowersUSMC
(25.94)
Submitted: 10/21/2021 2:11:43 PM :
Start Price:
$10.30
NASDAQ:ME Score:
-12.75
As world population grows,= more customers
Find the members with the highest scoring picks in ME.
chammond55 (95.16) Score: +24.06
The Score Leader is the player with the highest score across all their picks in ME.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| chammond55 | 95.16 | 11/12/2021 |
|
5Y | $12.26 | -25.45% | -1.39% | +24.06 | 0 Comment | |
| IPO2019 | 57.92 | 10/7/2021 |
|
5Y | $7.86 | +16.28% | +4.35% | +11.94 | 0 Comment | |
| JCDaniel | < 20 | 8/12/2021 |
|
5Y | $8.20 | +11.46% | +3.46% | +8.00 | 0 Comment | |
| AustinGreenTech | 21.21 | 10/4/2021 |
|
5Y | $8.25 | +10.79% | +7.00% | +3.79 | 0 Comment | |
| cruisin25 | 53.37 | 8/23/2021 |
|
3M | $8.59 | +6.40% | +2.67% | +3.73 | 0 Comment | |
| jscm86 | 59.00 | 9/2/2021 |
|
5Y | $8.76 | +4.34% | +1.21% | +3.13 | 0 Comment | |
| Byron111 | 96.78 | 8/23/2021 |
|
5Y | $8.90 | +2.70% | +3.10% | -0.41 | 0 Comment | |
|
TMFJoryko | 99.07 | 8/9/2021 |
|
5Y | $8.87 | +3.04% | +3.73% | -0.69 | 0 Comment |
| GoldMiner20 | 45.59 | 9/30/2021 |
|
5Y | $8.75 | +4.46% | +5.26% | -0.81 | 0 Comment | |
| sgengine7 | < 20 | 9/22/2021 |
|
5Y | $8.99 | +1.67% | +4.85% | -3.18 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
